Drugs

January 4, 2021 Audience: Consumer, Patient, Health Professional, Pharmacy January 4, 2021 — Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) have been
0 Comments
A research group investigated the use of gene therapy for treating inherited hearing loss. Around the world, there are roughly 466 million people who suffer from hearing loss, 60% of which can be attributed to a genetic cause. Over 120 genes are connected to hereditary deafness, many of which are variants present only in small
0 Comments
Adding arthritis drug baricitinib to remdesivir may reduce recovery time in adult patients hospitalized with COVID-19, according to a study. Scientists and healthcare professionals are working hard to find the best treatment that might benefit patients hospitalized with SARS-CoV-2. In a previous study, researchers observed that the remdesivir, an antiviral drug, was effective in patients
0 Comments
reltecimod Treatment for Organ Dysfunction or Failure in Patients with Necrotizing Soft Tissue Infection Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod to Treat Suspected Organ Dysfunction or Failure in Patients with Necrotizing Soft Tissue Infection (“Flesh-Eating Disease”) DURHAM, N.C. and NESS ZIONA, Israel, Dec. 10, 2020 /PRNewswire/ – Atox Bio today announced that the U.S. Food and
0 Comments
COVID-19 vaccines have been at the forefront of the media, and clinicians administered the first vaccinations in December 2020. However, the vaccines produced by Pfizer-BioNTech and Moderna raised public concern following the reports of potential allergic reactions.  As of the 4th January 2021, 4,563,260 Americans have received their first dose of the COVID-19 vaccine. According
0 Comments
Does the presence of hospital clowns help or hinder the recovery rate of patients? A recent review published by BMJ aimed to determine what effect if any, they have on patients being treated for acute and chronic conditions. Since the early 1900’s, hospital clowns have been using stories, magic, juggling, and other amusing tactics to
0 Comments
There is a large concern for the increasing popularity of vaping among young adults. Studies show that inhaling aerosolized e-liquids, which contain toxicants, can significantly affect respiratory health. Vitamin E acetate is used as an additive in vaping products and is by far one of the largest contributors to lung injuries in young adults. But
0 Comments
17 December 2020 –  GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved Benlysta (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard therapy. Lupus nephritis is a serious inflammation of the kidneys caused by systemic lupus erythematosus (SLE), the most common form
0 Comments
Treatment for Molluscum Contagiosum Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum WEST CHESTER, PA – Dec. 23, 2020 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it has resubmitted the
0 Comments
RALEIGH, N.C., December 21, 2020 – Merz Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA) for the treatment of patients aged 2 years and older with chronic sialorrhea, or drooling. Xeomin is the first and only FDA-approved neuromodulator with this indication and
0 Comments
New research investigates whether exposure to metals during pregnancy, particularly heavy metals such as lead, arsenic, and nickel, can have negative effects on the developing fetus. Heavy metals are essentially a general term for metals that could potentially harm humans or the environment in excessive amounts.  Some common heavy metals include lead, mercury, arsenic, nickel,
0 Comments
Treatment for Chronic Kidney Disease-Associated Pruritus Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Korsuva Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus STAMFORD, Conn., Dec. 28, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus
0 Comments
WALTHAM, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) — Sobi™, an international biopharmaceutical company dedicated to rare diseases, announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Kineret (anakinra) for the treatment of deficiency of IL-1 receptor antagonist (DIRA). DIRA is an ultra-rare, autoinflammatory disease caused by
0 Comments
A study reveals the airflow patterns inside a passenger car and how open windows can increase or decrease COVID-19 transmission risk. Researchers studied how airflow changes inside a car may worsen or reduce COVID-19 transmission risk in a first-of-its-kind study. They observed that opening windows – the more windows, the better – created airflow patterns
0 Comments
Treatment for Pharmacologic Mydriasis Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi NEW YORK–(BUSINESS WIRE)–Dec. 29, 2020– Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company with Phase 3 programs in presbyopia, myopia and mydriasis, today announced that it has submitted a New Drug Application (NDA) to the U. S. Food and Drug
0 Comments
December 18, 2020 — Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Iclusig (ponatinib) for adult patients with chronic-phase (CP) chronic myeloid leukemia (CML) with resistance or intolerance to at least two prior kinase inhibitors. The updated label includes
0 Comments
Drinking milk while breastfeeding may decrease the risk of allergies in children, according to a new study.  The occurrence of food allergies in infants and children may be reduced by drinking cow’s milk while breastfeeding, suggested by the results of a recent study from Northern Sweden. Researchers investigated the relationship between diet during pregnancy and lactation and allergy frequency in infants during their first year of life. A total of 637 families
0 Comments
Understanding the correlation between metabolic syndrome and COVID-19 may be crucial to improved treatment and outcomes. The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a global crisis affecting millions of people with more than 40 million confirmed cases worldwide and over a million COVID-19 related deaths. Particularly, the elderly
0 Comments
Treatment for Schizophrenia, Bipolar Disorder FDA Accepts Alkermes’ Resubmission of New Drug Application for ALKS 3831 DUBLIN, Dec. 29, 2020 /PRNewswire/ – Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the company’s New Drug Application (NDA) resubmission for ALKS 3831 (olanzapine/samidorphan) for the treatment of adults with schizophrenia and adults with
0 Comments
December 28, 2020 Audience: Consumer, Patient, Health Professional, Pharmacy Schaumburg, Illinois, Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level. This product may be contaminated with the bacteria Burkholderia lata. This is an expansion of the recall
0 Comments
An analysis of the current guidelines on how to talk to kids about weight. Currently, 18.4% of children are overweight, and the numbers are only increasing. Obesity in children leads to obesity in adults and complications associated with it: cardiovascular disease, diabetes, cancer, and more. With the childhood obesity epidemic and the resulting health concerns,
0 Comments
Outbreaks of infectious diseases have been recorded throughout history. Currently, SARS-CoV-2, a contagious virus that causes the disease called COVID-19, is impacting individuals worldwide. Many countries have set their sight on an effective vaccination program to end their infectious disease outbreaks. The term “herd immunity” has been mentioned in association with ending the COVID-19 outbreaks.
0 Comments
FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB) IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dec. 23, 2020– Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for once-daily 75 mg Gemtesa (vibegron), a beta-3 adrenergic receptor (β3) agonist,
0 Comments
December 23, 2020 Audience: Consumers December 23, 2020 — Shane Erickson, Inc. is voluntarily recalling lot 2020/05/11 and MFG: 2020/05/10 L/N: 20200510-3 of imc Wash-Free Hand Sanitizer 50 ml, 100 ml, 300 ml and Wash Free Hand Sanitizer 300 ml lot 2020/05/11 and Thrifty White Pharmacy Wash-Free Hand Sanitizer 300 ml lot 2020/05/11 listed in
0 Comments
FDA Approves Riabni (rituximab-arrx), a Biosimilar to Rituxan THOUSAND OAKS, Calif., Dec. 17, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Riabni (rituximab-arrx), a biosimilar to Rituxan® (rituximab), for the treatment of adult patients with Non-Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Granulomatosis with Polyangiitis (GPA)
0 Comments
New research investigates a new way to reduce postoperative pain and minimize opioid use in people undergoing surgery. Opioids are a class of medications that interact with the opioid receptors in the body.  They can have many therapeutic purposes, including pain relief, controlling coughs, treating diarrhea, and help people get over certain addictions when prescribed
0 Comments
Peripheral artery disease occurs when the peripheral arteries – most commonly in the legs – become narrow. The most common cause of peripheral artery disease is atherosclerosis, the build-up of fat and cholesterol inside the walls of the artery. Some research suggests that flavonoids could positively affect atherosclerosis, suggesting that eating foods that contain high
0 Comments